CloudMedx automates healthcare processes and provides a single unified data platform. It offers operations explorer, clinical explorer, financial explorer, chronic conditions explorer, and more. The company was founded in 2015 and is based in Palo Alto, California.
CloudMedX's Products & Differentiators
Clinical Insights for Care Teams: - Rapid Risk Stratification - Close Gaps in care - Reduce readmissions and costs - ER, Lab, and Pharmacy alerts
Expert Collections containing CloudMedX
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
CloudMedX is included in 3 Expert Collections, including Robotic Process Automation.
Robotic Process Automation
RPA refers to the software-enabled automation of data-intensive tasks that are low-skill but highly sensitive operationally, including data entry, transaction processing, and compliance.
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Latest CloudMedX News
Jul 27, 2023
" - https://www.reportlinker.com/p06480067/?utm_source=GNW , Koninklijke Philips N.V., Enlitic Inc., Cloudmedx Inc., Oncora Medical Inc., Microsoft Corporation, Path AI Inc., and Aidoc Medical Ltd. The global AI in medical devices market is expected to grow from $10.64 billion in 2022 to $15.42 billion in 2023 at a compound annual growth rate (CAGR) of 44.92%.The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, and affecting many every markets across the globe. The market is expected to reach $66.35 billion in 2027 at a CAGR of 44.04%. The AI in medical devices market consists of revenues earned by entities by providing AI in medical devices such as diagnosis and treatment planning, remote monitoring, and robotic surgery.The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in medical devices market also includes sales of diagnostic imaging systems, wearable devices, electronic health records (EHRs), robotic surgical systems, and AI monitoring devices, which are used in providing AI in medical devices services.Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. Artificial intelligence (AI) in medical devices refers to the use of advanced algorithms, machine learning techniques, and other AI-related technologies to enhance the performance and capabilities of medical devices. AI in medical devices improves diagnostic accuracy, assists with surgical procedures, predicts patient outcomes, and personalizes treatment plans. North America was the largest region in the AI in medical devices market in 2022. The regions covered in the AI in medical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The main types of deployments in AI in medical devices are cloud and on-premise.Cloud refers to a remote server network that allows data storage, processing, and management over the Internet instead of a local server or personal computer. It offers hardware, software, and services, and it includes various technologies such as context awareness, deep learning, machine learning, natural language processing, predictive analytics, and others. These are used for several applications, including patient care, treatment, diagnosis and monitoring, and others, and the main end-users are hospitals and healthcare providers, patients, pharmaceutical and biotechnology companies, and healthcare payers. The growing demand for wearables is expected to propel the growth of AI in medical devices market going forward.Wearables are small electronic devices worn on or inside the body that can capture and measure things such as physical activity, monitor health metrics, or display information. AI can be integrated into wearable medical devices to enhance their functionality and provide more personalized and accurate health monitoring.Additionally, AI-powered wearables can detect and alert users to abnormal or potentially dangerous health events, such as irregular heart rhythms or falls. Therefore, these factors boost AI in the medical device market. For instance, in November 2022, according to the reports shared by Vicert d.o.o., a US-based IT services and IT consulting company, in 2020, 30 percent of US people were using wearable technology for healthcare, and approximately 50 percent of users was relying on this technology daily. Nine out of ten (92 percent) users of AI smartwatches use them for fitness and health-related purposes. Additionally, 533.6 million AI medical devices were shipped in 2021. Therefore, the growing demand for wearables is driving the growth of AI in medical device market going forward. Technological advancements are a key trend gaining popularity in AI in medical devices market.Major companies operating in the AI in medical devices market are adopting new technologies to sustain their position in the market. For instance, in March 2022, Nvidia Corporation., a US-based computer hardware manufacturing company, launched the Clara Holoscan MGX, a platform for the medical device industry to develop and deploy real-time AI applications at the edge. This innovative technology platform offers a range of features designed to help companies build and bring to market medical devices that incorporate advanced AI capabilities, such as image and signal processing, natural language processing, and predictive analytics. Additionally, this platform also includes advanced security features and compliance with healthcare industry regulations to ensure the safety and privacy of patient data. This can process medical data in real time and provide insights for clinical decision-making. In February 2023, GE HealthCare Technologies Inc., a US-based healthcare technology and diagnostics company, acquired Caption Health Inc., for $3 billion. With the acquisition, GE HealthCare Technologies Inc. aimed to bring Caption AI to more clinicians and expand its use cases beyond cardiology to other medical specialties, such as primary care, emergency medicine, and obstetrics. Caption Health Inc. is a US-based medical technology company that produces artificial intelligence (AI) medical products. The countries covered in the AI in medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The AI in medical devices market research report is one of a series of new reports that provides AI in medical devices market statistics, including AI in medical devices industry global market size, regional shares, competitors with a AI in medical devices market share, detailed AI in medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the AI in medical devices industry. This AI in medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
CloudMedX Frequently Asked Questions (FAQ)
When was CloudMedX founded?
CloudMedX was founded in 2015.
Where is CloudMedX's headquarters?
CloudMedX's headquarters is located at 540 University Avenue, Palo Alto.
What is CloudMedX's latest funding round?
CloudMedX's latest funding round is Incubator/Accelerator - III.
How much did CloudMedX raise?
CloudMedX raised a total of $15.45M.
Who are the investors of CloudMedX?
Investors of CloudMedX include MedTech Innovator, Plug and Play Accelerator, Shangbay Capital, DFJ DragonFund, Plug and Play Cleveland and 8 more.
Who are CloudMedX's competitors?
Competitors of CloudMedX include Apixio and 4 more.
What products does CloudMedX offer?
CloudMedX's products include Clinical Explorer and 2 more.
Who are CloudMedX's customers?
Customers of CloudMedX include Anthem, UCSF, Barrow Neurological Institute, Dignity Health and Mount Sinai.
Compare CloudMedX to Competitors
Epic specializes in the development of software for healthcare organizations.
Kinometrix develops a risk assessment system to revolutionize the way clinicians monitor patient fall risk status and allows nurses to provide fall-prevention care. It is an artificial intelligence (AI) platform that uses EHR data to predict patient harm events in hospitals. The company was founded in 2017 and is based in Rockville, Maryland.
Decode Health is a precision medicine analytics company that fuels collaboration within pharmaceutical, diagnostic, and technology companies. The company leverages its platform and expertise in genomics, clinical data, social determinants of health, and other healthcare data sources, to bring actionable insights into focus quickly. It creates data assets, products, and services that improve patient outcomes and reduce costs. Projects include genomic data creation, biomarker discovery, RNA diagnostics, and broader population health analytics. Decode Health was founded in 2019 and is headquartered in Nashville, Tennessee.
Reveleer develops a healthcare data and analytics platform to offer health plans with a set of services. The platform offers risk adjustment, quality improvement, and audit initiatives which allow customers to manage projects completely in-house using their own resources as a full-service customer or using a collaborative model, and offers healthcare software companies an opportunity to connect. The company was founded in 2009 and is based in Glendale, California.
Arcadia is a population health management technology company that offers various data-related insights solutions. It helps providers and health plans deliver insights to advance care and research, drive strategic growth, and ensure financial success. It caters its services to healthcare enterprises. The company was founded in 2002 and is based in Boston, Massachusetts.
Innovaccer is a healthcare technology company developing a data activation platform for a patient-centered, connected care delivery continuum. It creates a unified patient record for the healthcare providers and payer-use to enable collaborative care delivery. The company was founded in 2013 and is based in San Francisco, California.